Denali Therapeutics Inc. (DNLI) Competitors & Peers
The 5 largest companies in the same industry as Denali Therapeutics Inc., by market value — each comparable links to its own dossier. Numbers are code-computed, never estimated.
| Ticker | Relationship | Price | Comparables |
|---|---|---|---|
| VRTX | Peer | $516.34 | P/E 29.8RSI 43Cap 130.0 B |
| REGN | Peer | $789.45 | P/E 19.5RSI 49Cap 81.3 B |
| ARGX | Peer | $995.77 | P/E 38.0RSI 53Cap 62.1 B |
| RVMD | Peer | $196.94 | RSI 41Cap 42.2 B |
| CSLLY | Peer | $31.75 | P/E 18.2RSI 71Cap 60.1 B |
How these relationships were derived
Every relationship below carries its provenance. A confirmed edge is sourced from a public filing or disclosure and links to it; an AI-inferred edge is surfaced by the relationship model and is unverified — shown for color, not as evidence.
Model-inferred relationships (unverified)
Suggested by the relationship model, with no public source on file. Treat each as a lead worth checking, not as evidence.
- SNYPartner
Sanofi partners with Denali to develop RIPK1 inhibitors for multiple sclerosis and Alzheimer's disease.
Model-inferred, unverified — treat as a lead, not evidence - BIIBPartner
Biogen partners with Denali to co-develop LRRK2 inhibitors for Parkinson's disease treatment.
Model-inferred, unverified — treat as a lead, not evidence